Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment
Clinical trial NCT03677557 · UNKNOWN
Trial details
- NCT number
- NCT03677557
- Sponsor
- Ottawa Hospital Research Institute
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-19
- Primary completion
- 2021-08-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.